Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by lightcycler technology

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3281-3289

  Nakao, Makoto ^a   Janssen, Johannes W G ^a   Flohr, Thomas ^a   Bartram, Claus R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLELISM; ARTICLE; CHILD; COMPUTER PROGRAM; CONTROLLED STUDY; DNA BINDING; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; CHILD; FLUORESCENT DYES; GENE REARRANGEMENT; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOGLOBULINS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, T-CELL, ACUTE; NEOPLASM, RESIDUAL; ORGANIC CHEMICALS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 0034047620     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pui, C. H., and Evans, W. E. Drug therapy: acute lymphoblastic leukemia. N. Engl. J. Med., 339: 605-615, 1998.
2. Campana, D., and Pui, C. H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85: 1416-1434, 1995.
3. Cave, H., van der Werff ten Bosch, J., Suciu, S.. Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B., and Vilmer, E. Clinical significance of minimal residual disease in childhood acute lymphohlastic leukemia. N. Engl. J. Med., 339: 591-598, 1998.
4. van Dongen, J. J., Seriu, T., Panzer-Grumayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., Gadner, H., van Wering, E. R., Ludwig, W. D., Basso, G., de Bruijn, M. A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W. C., Riehm, H., and Bartram, C. R. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352: 1731-1738, 1998.
5. Brisco, M. J., Tan, L. W., Orsborn, A. M., and Morley, A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, lor rare B-lymphocyte clones in a palyclonal population. Br. J. Haematol., 75: 163-167, 1990.
6. Maeda, Y., Horiuchi, F., Morita, S., Matsuda, M., Shirakawa, C., Masaki, H., Koyama, A., Hamazaki, H., Fujimoto, T., Irimajiri, K., and Horiuchi, A. Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis. Exp. Hematol., 22: 881-887, 1994.
7. Seriu, T., Hansen-Hagge, T. E., Erz, D. H., and Bartram, C. R. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction anal-yses based on clonospecific T cell receptor junctions. Leukemia, 9: 316-320, 1995.
8. Haber, M., Kwan, E., Zhu, L., Marshall, G. M., and Norris, M. D. Sensitive non-radioactive PCR detection of elonal T-cell receptor-gamma gene rearrangements in childhood acute lymphohlastic leukaemia. Br. J. Haematol., 98: 995-998, 1997.
9. Voena, C., Ladetto, M., Astolfi, M., Provan, D., Gribben, J. G., Boccadoro, M., Pileri, A., and Corradim, P. A novel nested-PCR strategy for the detection of rearranged immunoglohulin heavy-chain genes in B cell tumors. Leukemia, 11: 1793-1798, 1997.
10. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. Real time quantitative PCR. Genome Res., 6: 986-994, 1996.
11. Luthra, R., McBride, J. A., Cabanillas, F., and Sarris, A. Novel 5́ exonuclease-based real-time PCR assay for the detection of t(14;18)(q.32;q21) in patients with follicular lymphoma. Am. J. Pathol., 153: 63-68, 1998.
12. Gerard, C. J., Olsson, K., Ramanathan, R., Reading, C., and Hanania, E. G. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res., 58: 3957-3964, 1998.
13. Pongers-Willemse, M. J., Verhagen, O. J., Tibbe, G. J., Wijkhuijs, A. J., de Haas, V., Roovers, E., van der School, C. E., and van Dongen, J. J. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 12: 2006-2014, 1998.
14. Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., and Balis, U. J. The LightCyder™ a microvolume multisample fluorimeter with rapid temperature control. Biotechniques, 22: 176-181, 1997.
15. Ririe, K. M., Rasmussen, R. P., and Wittwer, C. T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem., 245: 154-160, 1997.
16. Kreuzer, K. A., Lass, U., Bohn, A., Landt, O., and Schmidt, C. A. LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res., 59: 3171-3174, 1999.
17. Nakao, M., Janssen, J. W. G., Seriu, T., and Bartram, C. R. Rapid and reliable detection of N-rm mutations in acute lymphohlastic leukemia by melting curve analysis using LighiCycler™ technology. Leukemia. 14: 312-315, 2000.
18. Hoclzer, D., Thiel, E., Löffler, H., Büchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., and Diedrich, H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71: 123-131, 1988.
19. Reiter, A., Schrappe, M., Ludwig, W. D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., Odenwald, E., Ritter, J., Mann, G., Welte, K., Gadner, H., and Riehm, H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patienls. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84: 3122-3133, 1994.
20. Aubin, J., Davi, F., Nguyen-Salomon, F., Leboeuf, D., Debert, C., Taher, M., Valensi. F., Canioni, D., Brotisse, N., Varel, B., Flandrin, G., and Macintyre, E. A. Description of a novel FRI IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia, 9: 471-479, 1995.
21. Nakao, M., Janssen, J. W. G., and Bartram, C. R. Duplex PCR facilitates the identification of immunoglobulin κ (IGK) gene rearrangements in acute lymphoblastic leukemia. Leukemia. 14: 218-219, 2000.
22. Pongers-Willemse, M. J., Seriu, T., Stolz, F., d'Aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C, R., Panzer-Grumayer, E. R., Biondi, A., San Miguel, J. F., and van Dongen, J. J. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblaslic leukemia using immunoglobulin and T cell receptor gene rearrangements and TALI deletions as PCR targets: report of the BIOMED-I Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia, 13: 110-118, 1999.
23. Langerak, A. W., Szczepanski, T., van der Burg. Wolvers-Tettero, I. L. M., and van Dongen J. J. M. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonalily assessment in suspect T cell proliferations. Leukemia, 11: 2192-2199, 1997.
24. Matsuda, F., Ishii, K., Bourvagnet, P., Kuma, K. I., Hayashida, H., Miyata, T., and Honjo, T. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med., 188: 2151-2162, 1998.